« Back to Where We Work
ICAP has partnered with the Government of Ethiopia since 2005, providing technical assistance to improve HIV prevention, care and treatment and malaria diagnosis and care. Our portfolio includes education and capacity building projects for nursing and midwifery and research on HIV and malaria.
We work at the national level with the Federal Ministry of Health (FMOH), regional health bureaus, laboratories and health care facilities in all 11 regions. Additional partners include the Ethiopian Public Health Institute (EPHI), universities and educational institutions, and international schools of public health.
In 2015, ICAP celebrated ten years of partnership in Ethiopia. Read ICAP in Ethiopia’s ten-year anniversary report here.
Technical Assistance for the Transition of Comprehensive HIV/AIDS Programs
ICAP is providing technical assistance to build the capacity of Ethiopia’s Ministry of Health, regional health bureaus, and universities to implement, monitor, and sustain the delivery of high-quality adult and pediatric HIV prevention, care and treatment.
ICAP is building the capacity of regional health bureaus to provide a full range of services, including HIV counseling and testing, prevention of mother-to-child transmission of HIV (PMTCT), adult and pediatric HIV treatment, care and support, TB/HIV integration, laboratory support, prevention of STIs, blood safety, infection prevention, support for strategic information systems, health systems strengthening, and transition of responsibilities to local partners. ICAP is also building the capacity of universities to provide pre-service medical education and in-service training.
Malaria Laboratory Diagnosis and Monitoring
ICAP is providing technical assistance to the FMOH, Ethiopia Public Health Institute, and regional reference laboratories to support malaria laboratory diagnosis and monitoring activities in four regions. (funded by the President’s Malaria Initiative through USAID)
Capacity Building and Education for Nursing & Midwifery
ICAP is working with the FMOH to expand the role of nurses, improve nursing care standards at health facilities and build nurses’ capacity to support quality improvement. Through its Nursing Education Partnership Initiative (NEPI), ICAP partners with Addis Ababa University, Arba Minch College of Health Sciences, and the University of Gondar to enhance teaching and learning and ensure an adequate number of well-trained and qualified nurses and midwives. Online at nepinetwork.org. (funded by PEPFAR through HRSA)
The ENRICH Study
The ENRICH study is a cluster randomized trial that is evaluating the effectiveness of a combination intervention package for the provision of isoniazid prevention therapy (IPT) for tuberculosis in HIV care and treatment programs in Ethiopia, as compared to the standard of care. (funded by PEPFAR through the NIH)
THE LSTART Study
The LSTART study is examining the multi-level factors associated with late antiretroviral therapy (ART) initiation in areas of sub-Saharan Africa and Ethiopia. Partners include CUNY School of Public Health, the HIV Center for Clinical and Behavioral Studies at Columbia University, and the Oromia Regional Bureau of Health. (funded by the NIH)
Technical Assistance for HIV Prevention, Care and Treatment
ICAP provided technical support at the national and regional level to implement and monitor adult and pediatric HIV prevention, care and treatment services, including blood safety, infection prevention, and strategic information systems. ICAP also supported hospitals and health centers providing HIV care. Working with regional reference laboratories, ICAP strengthened antiretroviral therapy monitoring, early infant diagnosis and quality assurance for HIV, and related laboratory tests. (funded by PEPFAR though the CDC)
To read more about the achievements of this project, read the project brief here.
Study on the Current Standard of Care for Malaria & Primaquine
ICAP evaluated the effectiveness of drugs currently used in Ethiopia against malaria, arthemeter-lumefantrine and chloroquine. The research is helping assess the safety and the efficacy of primaquine when used in combination with the existing treatment protocol. (funded by the Menzies School of Health Research)